Botox raises the eyebrows by weakening the muscles that pull them down, allowing the forehead’s only lifting muscle to work unopposed. The effect is subtle, typically a few millimeters, but that small shift can open up the eye area and create a more refreshed, arched look. The technique hinges on precise placement: injecting the right depressor muscles while leaving the elevator intact, a balance that varies from person to person and makes injector skill the biggest variable in the outcome.
Why Weakening Muscles Lifts the Brow
Your eyebrow position at any given moment is the result of a tug-of-war. The frontalis muscle, which spans your forehead, is the only muscle that pulls the brow upward. Working against it are several muscles that pull the brow downward and inward: the corrugator supercilii (the frown muscle), the procerus (the one that bunches the skin between your brows), the depressor supercilii, and the upper fibers of the orbicularis oculi (the ring muscle around each eye). These depressors are interconnected in ways that vary between individuals, contributing to differences in how people’s faces move and age.
Botox, or botulinum toxin type A, blocks nerve signals to whichever muscle it’s injected into, temporarily paralyzing it. Researchers hypothesized early on that selectively denervating the brow depressors would let the frontalis work unopposed, producing a slight brow elevation, and clinical studies have confirmed this is exactly what happens.
How Much Lift You Can Realistically Expect
If you’re imagining a dramatic lift, recalibrate. The numbers from clinical research are consistent but modest. A systematic review covering 585 patients found that the highest elevation occurred at the lateral (outer) brow, ranging from about 0.4 to 4.8 mm depending on technique and individual anatomy. One early study measuring temporal brow lift specifically found an average elevation of about 1 mm from the midpupil but nearly 5 mm when measured from the lateral corner of the eye, which better captures the arching effect at the tail of the brow. Another small study of seven patients found that five showed 1 to 3 mm of elevation, while two showed no change at all.
Those numbers might sound underwhelming on paper, but a couple of millimeters at the brow can make a visible difference in how open and awake the eye area looks, especially in photographs. The lift tends to be most pronounced at the outer brow, which is exactly where many people want that arched, lifted appearance. Still, if you’re hoping for the kind of change that a surgical brow lift delivers, Botox alone won’t get you there. Think of it as a refinement, not a transformation.
Where the Injections Are Placed
The injection sites depend on which part of the brow you want to lift. For a general brow lift, the targets are the depressor muscles: the corrugator supercilii, the procerus, and sometimes the upper orbicularis oculi along the orbital rim. By weakening these, the frontalis is free to pull the brow up without resistance.
Research on injection technique has gotten more specific over time. A study examining a newer botulinum toxin formulation found that positive brow outcomes were achieved with deep injections into the medial corrugator, superficial injections into the lateral corrugator placed between the midpupil line and the outer edge of the iris, and deep midline injections into the procerus. The depth matters because the corrugator and frontalis overlap in certain areas, and injecting too superficially in the wrong spot can inadvertently weaken the frontalis instead of the corrugator, defeating the purpose entirely.
Some injectors also place small doses just beneath the lateral brow along the orbital rim to relax the upper fibers of the orbicularis oculi. This targets the muscle that acts as a depressor at the tail of the brow, further freeing up the lateral frontalis to lift. The key principle across all of these approaches is the same: paralyze what pulls down, leave alone what pulls up.
Dose and How the Timeline Unfolds
The amount of Botox used for a brow lift is typically part of a glabellar treatment (the area between and just above the brows), with adjustments to emphasize the lifting effect. Research has shown that 20 to 40 units of botulinum toxin A injected into the glabella produced an immediate lateral brow elevation, followed by a central and medial elevation that peaked at about 12 weeks after treatment. Interestingly, the lowest dose studied, 10 units, actually produced a mild brow droop along with a weaker overall response.
That finding about the low dose is worth paying attention to. It suggests there’s a threshold effect: too little toxin may partially weaken the depressors without fully disabling them, and the slight swelling or diffusion from the injection itself can temporarily weigh the brow down. Going too low on dosing in an attempt to be conservative can backfire. This is one reason why the procedure benefits from an experienced injector who understands dose-response relationships rather than someone who defaults to the smallest possible amount.
The timeline is also less straightforward than many people expect. Lateral elevation tends to happen first because the lateral corrugator fibers are thinner and respond quickly. The medial and central brow take longer to reach peak position, sometimes not until three months out. If you’re evaluating your results at the two-week mark, you may not yet be seeing the full effect at the inner brow.
The Spock Brow Problem
The most talked-about complication of a Botox brow lift is the “Spock brow” or Mephistopheles effect, where the outer brow shoots up into an exaggerated, pointy arch while the inner brow stays flat or even drops. It looks unnatural and immediately signals that something cosmetic went wrong.
This happens when the injection points are placed too high or too laterally, hitting the lower fibers of the frontalis instead of the corrugator’s tail. When the frontalis is weakened medially but left untouched laterally, the lateral fibers recruit harder to compensate, pulling the outer brow up into that telltale peak. One common mistake, according to a recent analysis, is when a practitioner follows guidelines advising injection “at least 1 cm above the supraorbital rim” but misinterprets this as 1 cm above the visible brow hair. Since the bony rim sits below the brow line, this miscalculation pushes the injection point up into frontalis territory.
The fix for a Spock brow, if it happens, is a small corrective injection of Botox into the frontalis at the apex of the unwanted peak. A couple of units placed at the point of maximum elevation can relax the overactive lateral fibers and bring the brow back to a more natural contour. Some practitioners also inject the relevant brow depressors to rebalance the overall dynamic. It’s a solvable problem, but obviously one you’d rather avoid in the first place.
Eyelid Drooping and Other Side Effects
Eyelid drooping, or blepharoptosis, is a different complication from brow drooping and involves a different muscle entirely. It occurs when Botox migrates from the injection site into the orbit and weakens the levator palpebrae superioris, the muscle that lifts the upper eyelid. The onset is typically 3 to 14 days after injection, and it eventually resolves on its own as the toxin wears off. In the meantime, prescription eye drops containing apraclonidine or oxymetazoline can partially reverse the droop by stimulating a secondary eyelid-elevating muscle.
Anatomical research has identified a specific risk factor: some people have a supraorbital foramen, an opening in the bone above the eye socket, that can act as a shortcut for the toxin to travel from the brow area directly into the orbital roof along the neurovascular bundle. This anatomical variant isn’t something you can identify without imaging, which is one reason eyelid ptosis remains an unpredictable complication even with careful technique.
A systematic review of brow rejuvenation complications found that in the botulinum toxin studies, the most common issue was bruising at about 1.7% of cases, followed by flu-like symptoms, persistent wrinkles, and trace ptosis each at about 0.7%, while eyelid ptosis and excessive brow elevation each occurred in roughly 0.3% of cases. These are low rates overall, and nearly all complications are temporary given Botox’s limited duration of action.
Addressing Pre-Existing Asymmetry
Almost nobody has perfectly symmetrical brows, and Botox can actually be used to correct noticeable differences between the two sides. A study of 683 patients seeking wrinkle reduction found that the minimal amount of brow asymmetry noticeable to patients themselves was about 2 mm. Among 115 patients with asymmetry exceeding that threshold, targeted botulinum toxin injections were used to rebalance brow positions.
The principle is straightforward: on the side with the lower brow, you inject more aggressively into the depressors to let the frontalis lift it. On the side with the higher brow, you might inject a small amount into the frontalis itself to bring it down slightly. The challenge is that the correction is temporary and needs to be reproduced at each treatment cycle, which means the injector needs to measure and map the asymmetry every time. If you have significant brow asymmetry that bothers you, it’s worth discussing at your first consultation, because a generic treatment plan that ignores it could actually make the unevenness more obvious once the muscles around it are relaxed.
Combining Botox with Other Treatments
Botox alone delivers a modest lift, but combining it with other modalities can amplify the result. A study of periocular rejuvenation combined micro-focused ultrasound with visualization (a device-based skin-tightening treatment) applied across the area above the brow and around the eye, dermal filler injected into the sunken upper eyelid and lateral brow, and Botox administered into the forehead, glabella, crow’s feet, and lateral orbital rim below the brow. The combination produced an average eyebrow height increase of 3.5 mm and a maximum increase of 3.9 mm at 12 weeks.
That 3.5 mm average is considerably higher than what most Botox-only studies report, suggesting the combination produces a synergistic effect. The ultrasound tightens the skin and soft tissue from above, the filler adds structural support beneath the brow, and the Botox releases the muscular downward pull. Each component addresses a different contributor to brow descent. This kind of multimodal approach is increasingly common in aesthetic practice, especially for patients who want more than Botox alone can deliver but aren’t ready for surgery.
How Botox Compares to Surgical Brow Lifts
Non-surgical brow lifting with Botox and surgical brow lifting serve different purposes and different patients. Botox is temporary, typically lasting three to four months before the muscles recover and the brow settles back. It requires no downtime, carries low complication rates, and is easy to adjust or correct if the result isn’t ideal. A narrative review of eyebrow lifting techniques noted that non-surgical methods are temporary, require less experience to perform, and are easier to correct if complications arise.
Surgical brow lifts, by contrast, come in several forms including endoscopic lifts, direct brow lifts, and trans-blepharoplasty approaches, each with different scar profiles and recovery times. They produce more dramatic and longer-lasting elevation but carry higher stakes: nerve damage, scarring, infection, and the irreversibility of overcorrection. For someone with significant brow ptosis caused by skin laxity and soft tissue descent, Botox alone won’t address the underlying structural problem. For someone in their thirties or forties who just wants a subtle lift and a more open eye area, Botox is often the more proportionate choice.
Many surgeons actually use Botox as a diagnostic tool before recommending surgery: if a patient responds well to a chemical brow lift, it confirms that muscular pull is a major contributor to their brow position, and a surgical intervention targeting those muscles will likely produce a good result. If Botox doesn’t move the brow much, the problem may be more about skin excess and tissue descent, which only surgery can fix.
Why Individual Anatomy Matters More Than a Standard Protocol
One theme running through the clinical literature on Botox brow lifts is the sheer variability of forehead anatomy between people. The frontalis muscle doesn’t have the same shape, thickness, or lateral extent in everyone. In some people it reaches all the way to the temples; in others it stops well short of the lateral brow, meaning there’s no elevator muscle at the outer brow to take advantage of once the depressors are relaxed. The depressor muscles vary too: the corrugator can be thick and deeply seated in one patient and thin and superficial in another, changing the ideal injection depth and dose.
Research on the functional anatomy of the frontalis and glabellar complex has emphasized that dose and injection technique must be individualized based on this variable anatomy, muscle mass, and patient goals. Anatomical studies have also revealed that the depressor supercilii connects to midface muscles in patterns that differ from person to person, influencing how brow position responds to treatment of the glabellar area. This is why a cookie-cutter approach, the same five injection points and the same 20 units for every patient, produces inconsistent results. The injectors who get the best outcomes are the ones who assess muscle function dynamically, asking patients to frown, raise their brows, and squint before marking injection sites, then adjusting their plan based on what they see moving under the skin.
If you’re considering a Botox brow lift, it’s worth asking your provider how they assess brow depressor function and whether they adjust their technique based on your specific anatomy. A provider who uses a standardized template for every face is more likely to produce the complications described above, from Spock brows to asymmetric results, than one who treats each forehead as a unique landscape. The difference between a skilled injector and an average one isn’t the product they use; it’s how well they read the anatomy in front of them.